Raras
Buscar doenças, sintomas, genes...
Síndrome de Usher tipo 2
ORPHA:231178CID-10 · H35.5CID-11 · LD2H.4DOENÇA RARA

Síndrome caracterizada por perda auditiva neurossensorial congênita bilateral que é leve a moderada nas frequências baixas e grave a profunda nas frequências mais altas, sem anormalidades no sistema vestibular e retinite pigmentosa.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome caracterizada por perda auditiva neurossensorial congênita bilateral que é leve a moderada nas frequências baixas e grave a profunda nas frequências mais altas, sem anormalidades no sistema vestibular e retinite pigmentosa.

Pesquisas ativas
1 ensaio
7 total registrados no ClinicalTrials.gov
Publicações científicas
71 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
2.2
Denmark
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
8 sintomas
👂
Ouvidos
5 sintomas
🧠
Neurológico
2 sintomas
💪
Músculos
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

90%prev.
Perda visual
Muito frequente (99-80%)
90%prev.
Distrofia de cones e bastonetes
Muito frequente (99-80%)
90%prev.
Anormalidade da orelha interna
Muito frequente (99-80%)
90%prev.
Deficiência auditiva neurossensorial
Muito frequente (99-80%)
90%prev.
Hipopigmentação da íris
Muito frequente (99-80%)
90%prev.
Escotoma
Muito frequente (99-80%)
23sintomas
Muito frequente (7)
Frequente (8)
Ocasional (5)
Muito raro (1)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 23 características clínicas mais associadas, ordenadas por frequência.

Perda visualVisual loss
Muito frequente (99-80%)90%
Distrofia de cones e bastonetesRod-cone dystrophy
Muito frequente (99-80%)90%
Anormalidade da orelha internaAbnormality of the inner ear
Muito frequente (99-80%)90%
Deficiência auditiva neurossensorialSensorineural hearing impairment
Muito frequente (99-80%)90%
Hipopigmentação da írisIris hypopigmentation
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico71PubMed
Últimos 10 anos47publicações
Pico20208 papers
Linha do tempo
2026Hoje · 2026🧪 1993Primeiro ensaio clínico📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

WHRNWhirlinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear. Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear. In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

CytoplasmCell projection, stereociliumCell projection, growth conePhotoreceptor inner segmentSynapse

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 31

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
101.0 TPM
Testículo
78.7 TPM
Pituitária
61.5 TPM
Útero
52.7 TPM
Ovário
35.9 TPM
OUTRAS DOENÇAS (4)
Usher syndrome type 2Dautosomal recessive nonsyndromic hearing loss 31Usher syndrome type 2hearing loss, autosomal recessive
HGNC:16361UniProt:Q9P202
ADGRV1Adhesion G-protein coupled receptor V1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

G-protein coupled receptor which has an essential role in the development of hearing and vision. Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production. Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear. In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inh

LOCALIZAÇÃO

Cell membraneCell projection, stereocilium membranePhotoreceptor inner segment

VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Usher syndrome 2C

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

OUTRAS DOENÇAS (4)
Usher syndrome type 2Cfebrile seizures, familial, 4Usher syndrome type 2generalized epilepsy with febrile seizures plus
HGNC:17416UniProt:Q8WXG9
USH2AUsherinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. In the inner ear, required for the maintenance of the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells. In retina photoreceptors, the USH2 complex is required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

Cell projection, stereocilium membraneSecreted

MECANISMO DE DOENÇA

Usher syndrome 2A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Fígado
0.8 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Cerebelo
0.2 TPM
Coração - Átrio
0.2 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 39Usher syndrome type 2AUsher syndromeretinitis pigmentosa
HGNC:12601UniProt:O75445
MYO7AUnconventional myosin-VIIaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photore

LOCALIZAÇÃO

CytoplasmCytoplasm, cell cortexCytoplasm, cytoskeletonSynapse

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1B

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.8 TPM
Glândula adrenal
40.7 TPM
Pituitária
27.6 TPM
Baço
20.4 TPM
Fígado
12.7 TPM
OUTRAS DOENÇAS (9)
autosomal dominant nonsyndromic hearing loss 11autosomal recessive nonsyndromic hearing loss 2Usher syndrome type 1Bnonsyndromic genetic hearing loss
HGNC:7606UniProt:Q13402
PDZD7PDZ domain-containing protein 7Modifying germline mutation inTolerante
FUNÇÃO

In cochlear developing hair cells, essential in organizing the USH2 complex at stereocilia ankle links. Blocks inhibition of adenylate cyclase activity mediated by ADGRV1

LOCALIZAÇÃO

Cell projection, ciliumNucleusCell projection, stereocilium

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 57

A form of non-syndromic, sensorineural deafness characterized by symmetric, bilateral hearing loss with onset in early childhood. Vestibular function is preserved. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB57 severity ranges from moderate to severe.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
35.8 TPM
Cérebro - Hemisfério cerebelar
31.2 TPM
Pituitária
10.4 TPM
Brain Frontal Cortex BA9
10.3 TPM
Córtex cerebral
10.1 TPM
OUTRAS DOENÇAS (4)
hearing loss, autosomal recessive 57Usher syndrome type 2CUsher syndrome type 2Usher syndrome type 2A
HGNC:26257UniProt:Q9H5P4

Variantes genéticas (ClinVar)

4,684 variantes patogênicas registradas no ClinVar.

🧬 PDZD7: NM_001195263.2(PDZD7):c.1297C>A (p.Arg433Ser) ()
🧬 PDZD7: NM_001195263.2(PDZD7):c.1752T>G (p.Tyr584Ter) ()
🧬 PDZD7: NM_001195263.2(PDZD7):c.121C>T (p.Arg41Ter) ()
🧬 PDZD7: NM_001195263.2(PDZD7):c.166del (p.Arg56fs) ()
🧬 PDZD7: NM_001195263.2(PDZD7):c.1468_1489dup (p.Ala497fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 112 variantes classificadas pelo ClinVar.

84
28
Patogênica (75.0%)
VUS (25.0%)
VARIANTES MAIS SIGNIFICATIVAS
USH2A: NC_000001.11:g.215741537_215741540del [Likely pathogenic]
USH2A: NM_206933.4(USH2A):c.784+14389G>T [Conflicting classifications of pathogenicity]
ADGRV1: NM_032119.4(ADGRV1):c.2726T>C (p.Ile909Thr) [Conflicting classifications of pathogenicity]
ADGRV1: NM_032119.4(ADGRV1):c.1310G>A (p.Arg437Gln) [Conflicting classifications of pathogenicity]
USH2A: NM_206933.4(USH2A):c.1860C>A (p.Cys620Ter) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 24
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 6 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de Usher tipo 2

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

7 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
47 papers (10 anos)
#1

Characterization of Usher Syndrome Type 2-Associated Proteins in the Retina via Affinity Purification-Mass Spectrometry.

Molecular &amp; cellular proteomics : MCP2026 Feb 05

Usher syndrome is the leading cause of inherited deaf-blindness, with type 2 (Usher syndrome type 2, USH2) being the most common form. USH2A, ADGRV1, and WHRN are the three known USH2 causative genes, which are also linked to isolated retinal degeneration and hearing loss. These genes encode usherin, ADGRV1, and whirlin, respectively, collectively called USH2 proteins. These proteins form a multiprotein complex (USH2 complex) at the periciliary membrane in retinal photoreceptors and at the stereociliary ankle link in inner ear hair cells. The molecular function of the USH2 complex and its disease mechanisms are poorly understood. Currently, there is no cure for diseases caused by mutations in the three USH2 genes. In this study, we employed multiple affinity purification methods combined with mass spectrometry to systematically identify the interaction partners of USH2 proteins in the retina. The ADGRV1 intracellular bait pulled down proteins involved in actin-based cell projections, the chaperone-containing TCP-1 complex, and the Bardet-Biedl syndrome complex. The extracellular domains of ADGRV1 and usherin pulled down proteins related to peptidase regulation, collagen biosynthesis and modification, and elastic fiber formation. The EAR/EPTP repeats of ADGRV1 specifically pulled down TGFβ signaling proteins. Further immunoprecipitation experiments identified, with high confidence, Gαi and Gαq as ADGRV1-interacting proteins, and retinal degeneration and ciliary proteins as interaction partners of USH2 proteins. We also demonstrated that the usherin extracellular domains interact with each other and with ADGRV1. Overall, these findings suggest that the USH2 complex connects the extracellular matrix (ECM) to the intracellular actin network, signals through Gαi and Gαq, and participates in ECM remodeling, TGFβ signaling, cell adhesion, and ciliary function in photoreceptors.

#2

The BBS/CCT chaperonin complex ensures the localization of the adhesion G protein-coupled receptor ADGRV1 to the base of primary cilia.

Frontiers in cell and developmental biology2025

Primary cilia are antenna-like sensory organelles present on almost all eukaryotic cells. Their sensory capacity relies on receptors, in particular G-protein-coupled receptors (GPCRs) which localize to the ciliary membrane. Here we show that ADGRV1, a member of the GPCR subfamily of adhesion GPCRs, is part of a large protein network, interacting with numerous proteins of a comprehensive ciliary proteome. ADGRV1 is localized to the base of prototypic primary cilia in cultured cells and the modified primary cilia of retinal photoreceptors, where it interacts with TRiC/CCT chaperonins and the Bardet Biedl syndrome (BBS) chaperonin-like proteins. Knockdown of ADGRV1, CCT2 and 3, and BBS6 result in common ciliogenesis phenotypes, namely reduced ciliated cells combined with shorter primary cilia. In addition, the localization of ADGRV1 to primary cilia depends on the activity of a co-complex of TRiC/CCT chaperonins and the BBS chaperonin-like proteins. In the absence of components of the TRiC/CCT-BBS chaperonin co-complex, ADGRV1 is depleted from the base of the primary cilium and degraded via the proteasome. Defects in the TRiC/CCT-BBS chaperonin may lead to an overload of proteasomal degradation processes and imbalanced proteostasis. Dysfunction or absence of ADGRV1 from primary cilia may underly the pathophysiology of human Usher syndrome type 2 and epilepsy caused by mutations in ADGRV1.

#3

Epidemiological and genetic insights of Usher syndrome in Turkish population: A cross-sectional preliminary study from University of Health Sciences, Turkey.

The Journal of international medical research2025 Oct

ObjectiveThis current cross-sectional study aimed to investigate the demographic characteristics and molecular epidemiology of patients with Usher syndrome in the Turkish population.MethodsPatients who were followed up with a preliminary diagnosis of Usher syndrome from various regions of the country were included in the study. After a review of patients' medical histories, all underwent ophthalmological and otorhinolaryngological examinations. Mutations reported in previous studies in MYO7A, PCDH15, USH1C, CDH23, and USH2A were investigated using Sanger sequencing.ResultsFourteen (29.2%) patients had Usher syndrome type 1 and 16 (33.3%) had type 2. Eighteen (37.5%) patients could not be typed. We detected mutations in MYO7A (c.1343 + 1 G > A) in seven patients (six heterozygous and one homozygous) from seven families clinically compatible with Usher syndrome type 2 (rather than Usher syndrome type 1, as was expected based on previous studies).ConclusionsOur preliminary findings suggest that the proportions of patients with Usher syndrome type 1 and Usher syndrome type 2 in the Turkish population were almost equal, and none of our patients was clinically compatible with Usher syndrome type 3. Although previous studies reported that mutations in MYO7A rarely caused Usher syndrome type 2, in the Turkish population, MYO7A alleles may be hypomorphic and manifest as a milder phenotype in Usher syndrome compared with other populations.

#4

Inherited retinal diseases in Kentucky: diagnostic yield, gene variants, and novel mutations in a U.S. population.

BMC medical genomics2025 Aug 28

Inherited retinal diseases (IRDs) are a group of heterogeneous conditions leading to visual impairment and blindness with over 280 associated genes identified so far. This study aims to provide an initial characterization of the clinical and genetic landscape of IRDs in the United States with a cohort from Kentucky and contribute to the existing knowledge from studies in other regions. This single-academic center retrospective analysis was conducted on patients seen at the University of Kentucky Ophthalmic Genetic Services from January 2019 to March 2022 with a diagnosis of or concern for unspecified IRD and who underwent subsequent genetic testing with an IRD panel. The study included 366 subjects with a pre-genetic testing IRD diagnosis, with an age range from 9 to 87 years old and mean age of 42.11 years. The most common pre-genetic diagnoses were retinitis pigmentosa (RP) in 116 subjects (31.69%), referral for ‘concern for unspecified IRD’ in 107 subjects (29.23%), and macular dystrophy in 31 subjects (8.46%). The diagnostic yield of genetic testing for rod-cone dystrophy (RCD) cases was 83.89%. The five most common genetic testing confirmed diagnoses were RP, Usher syndrome type 2 (USH2A), Stargardt disease (STGD), Bardet-Biedl syndrome (BBS), and Usher syndrome type 1 (USH1). A total of 46 individual genes had pathogenic variants. The three most frequently pathogenic genes were RHO, USH2A, and ABCA4, with 5 pathogenic variants within RHO, 20 within USH2A, and 17 within ABCA4. Five novel variants were identified across the WFS1, ARSG, USH2A, ADGRV1, and PCDH15 genes. This study characterizes the genetic landscape of IRDs in a Kentucky cohort, with pathogenic variants in 46 genes, including five novel variants. These novel variants highlight the need for continued research to identify more population-specific variants. The findings highlight the value of genetic testing and contribute to advancing IRD research and care. ClinicalTrials.gov registration number: NCT06177977. First posted date: 12/20/2023. The online version contains supplementary material available at 10.1186/s12920-025-02186-5.

#5

Haploinsufficiency of Whrn Contributes to Progressive Sensorineural Hearing Loss in C57BL6 Mice.

Journal of the Association for Research in Otolaryngology : JARO2025 Jun

Whrn, encoding whirlin, is one of the genes highly relevant to Usher syndrome (USH) that has been known as an autosomal recessive genetic disorder that is characterized with sensorineural hearing loss with retinitis pigmentosa. Although recent studies on the other USH genes, PDZD7 and Ush1 g, showed a possibility of haploinsufficiency effect, the potential contribution of heterozygous Whrn loss to hearing loss remains unclear. To investigate the effect of Whrn haploinsufficiency, we conducted a longitudinal study assessing auditory function in heterozygous Whrn mutant (Whrn+/-) mice in which long isoform of Whrn was deleted by replacing exon 1 with Neo cassette without disturbing short isoform. The threshold of auditory brainstem responses (ABRs) was measured on 135 Whrn+/- mice and littermate 133 wild-type (WT) mice from 1 to 6 months of ages. From those data, the threshold from male and female were separately analyzed to investigate sex-dependent effect. To further investigate underlie mechanisms, hair cell death was investigated using immunohistostaining from 4 to 5 WT, 5 female Whrn+/-, and 7 male Whrn+/- mice at 4-5 months old. Hearing threshold was significantly increased with aging in Whrn+/- mice compared to WT controls. Both WT and Whrn+/- mice exhibited sex-dependent variations in hearing sensitivity. Notably, Whrn+/- males showed a progressive hearing loss with age, while Whrn+/- females exhibited elevated hearing thresholds as early as 1-2 month of age compared to WT females. These results provide evidence for a haploinsufficiency effect of Whrn on auditory function and highlight its potential role in progressive sensorineural hearing loss.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC24 artigos no totalmostrando 47

2026

Characterization of Usher Syndrome Type 2-Associated Proteins in the Retina via Affinity Purification-Mass Spectrometry.

Molecular &amp; cellular proteomics : MCP
2025

Epidemiological and genetic insights of Usher syndrome in Turkish population: A cross-sectional preliminary study from University of Health Sciences, Turkey.

The Journal of international medical research
2025

Inherited retinal diseases in Kentucky: diagnostic yield, gene variants, and novel mutations in a U.S. population.

BMC medical genomics
2025

Haploinsufficiency of Whrn Contributes to Progressive Sensorineural Hearing Loss in C57BL6 Mice.

Journal of the Association for Research in Otolaryngology : JARO
2025

The BBS/CCT chaperonin complex ensures the localization of the adhesion G protein-coupled receptor ADGRV1 to the base of primary cilia.

Frontiers in cell and developmental biology
2024

Usher Syndrome Type 2 in An Iranian Family: A Novel Founder Variation in The USH2A Gene.

Cell journal
2024

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire.

Investigative ophthalmology &amp; visual science
2025

Optical coherence tomography (OCT) and OCT-angiography in syndromic versus non-syndromic USH2A-associated retinopathy.

European journal of ophthalmology
2024

Functional Vision in Patients With Biallelic USH2A Variants.

American journal of ophthalmology
2023

Allelic hierarchy for USH2A influences auditory and visual phenotypes in South Korean patients.

Scientific reports
2024

The effects of ush2a gene knockout on vesicle transport in photoreceptors.

Gene
2023

USH2A mutational spectrum causing syndromic and non-syndromic retinal dystrophies in a large cohort of Mexican patients.

Molecular vision
2023

Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome type 2 caused by biallelic variants in the USH2A gene.

Stem cell research
2023

The Enigmatic Genetic Landscape of Hereditary Hearing Loss: A Multistep Diagnostic Strategy in the Italian Population.

Biomedicines
2023

Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.

American journal of ophthalmology
2023

Cone Structure and Function in RPGR- and USH2A-Associated Retinal Degeneration.

American journal of ophthalmology
2022

Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A.

International journal of molecular sciences
2022

Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity.

American journal of ophthalmology
2022

Affinity purification of in vivo assembled whirlin-associated protein complexes from the zebrafish retina.

Journal of proteomics
2022

Investigating Biomarkers for USH2A Retinopathy Using Multimodal Retinal Imaging.

International journal of molecular sciences
2021

Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush.

International journal of molecular sciences
2021

Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).

American journal of medical genetics. Part A
2022

Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.

Human genetics
2022

Photodynamic therapy for vasoproliferative tumour associated with retinitis pigmentosa and Usher syndrome type 2.

Clinical &amp; experimental optometry
2021

Peripheral Anomalies in USH2A Cause Central Auditory Anomalies in a Mouse Model of Usher Syndrome and CAPD.

Genes
2020

Targeted exome sequencing identified a novel USH2A mutation in a Chinese usher syndrome family: a case report.

BMC ophthalmology
2020

The lived experiences of work and health of people living with deaf-blindness due to Usher syndrome type 2.

International journal of qualitative studies on health and well-being
2020

The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.

Translational vision science &amp; technology
2020

USH2A-retinopathy: From genetics to therapeutics.

Experimental eye research
2020

Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.

American journal of ophthalmology
2020

Identification of novel USH2A mutations in patients with autosomal recessive retinitis pigmentosa via targeted next‑generation sequencing.

Molecular medicine reports
2020

Mutation screening of the USH2A gene reveals two novel pathogenic variants in Chinese patients causing simplex usher syndrome 2.

BMC ophthalmology
2020

Clinical and preclinical therapeutic outcome metrics for USH2A-related disease.

Human molecular genetics
2019

Studies of the Periciliary Membrane Complex in the Syrian Hamster Photoreceptor.

Advances in experimental medicine and biology
2019

Aberrant Splicing Events Associated to CDH23 Noncanonical Splice Site Mutations in a Proband with Atypical Usher Syndrome 1.

Genes
2019

Life strategies of people with deafblindness due to Usher syndrome type 2a - a qualitative study.

International journal of qualitative studies on health and well-being
2019

Identification of a Potential Founder Effect of a Novel PDZD7 Variant Involved in Moderate-to-Severe Sensorineural Hearing Loss in Koreans.

International journal of molecular sciences
2019

Unanticipated prognosis for a patient with type 2 Usher syndrome.

Documenta ophthalmologica. Advances in ophthalmology
2018

Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2.

Stem cell research
2018

Central Retina Functional Damage in Usher Syndrome Type 2: 22 Years of Focal Macular ERG Analysis in a Patient Population From Central and Southern Italy.

Investigative ophthalmology &amp; visual science
2018

[Vitreous cyst associated with Usher syndrome type 2: A case report].

Journal francais d'ophtalmologie
2017

[Usher syndrome: about a case].

The Pan African medical journal
2016

Compound heterozygous MYO7A mutations segregating Usher syndrome type 2 in a Han family.

International journal of pediatric otorhinolaryngology
2015

Choroidal Thickness Analysis in Patients with Usher Syndrome Type 2 Using EDI OCT.

Journal of ophthalmology
2015

Duane retraction syndrome type 1 with Usher syndrome type 2: an unreported association.

Journal of pediatric ophthalmology and strabismus
2015

Cognitive skills and reading in adults with Usher syndrome type 2.

Frontiers in psychology
2015

USH2 caused by GPR98 mutation diagnosed by massively parallel sequencing in advance of the occurrence of visual symptoms.

The Annals of otology, rhinology, and laryngology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de Usher tipo 2.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de Usher tipo 2

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Characterization of Usher Syndrome Type 2-Associated Proteins in the Retina via Affinity Purification-Mass Spectrometry.
    Molecular &amp; cellular proteomics : MCP· 2026· PMID 41654259mais citado
  2. The BBS/CCT chaperonin complex ensures the localization of the adhesion G protein-coupled receptor ADGRV1 to the base of primary cilia.
    Frontiers in cell and developmental biology· 2025· PMID 40103630mais citado
  3. Epidemiological and genetic insights of Usher syndrome in Turkish population: A cross-sectional preliminary study from University of Health Sciences, Turkey.
    The Journal of international medical research· 2025· PMID 41200749mais citado
  4. Inherited retinal diseases in Kentucky: diagnostic yield, gene variants, and novel mutations in a U.S. population.
    BMC medical genomics· 2025· PMID 40877827mais citado
  5. Haploinsufficiency of Whrn Contributes to Progressive Sensorineural Hearing Loss in C57BL6 Mice.
    Journal of the Association for Research in Otolaryngology : JARO· 2025· PMID 40360853mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:231178(Orphanet)
  2. MONDO:0016484(MONDO)
  3. GARD:5440(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q32143480(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de Usher tipo 2

ORPHA:231178 · MONDO:0016484
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
CID-10
H35.5 · Distrofias hereditárias da retina
CID-11
Ensaios
1 ativos
Início
Infancy, Neonatal
Prevalência
2.2 (Denmark)
MedGen
UMLS
C0339534
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades